Related Experiment Videos
Transcriptional Silencing of Retroviral Vectors
A.H. Lund1, M. Duch, F.S. Pedersen
1Department of Molecular and Structural Biology, University of Aarhus, Denmark.
Abstract:
Although retroviral vector systems have been found to efficiently transduce a variety of cell types in vitro, the use of vectors based on murine leukemia virus in preclinical models of somatic gene therapy has led to the identification of transcriptional silencing in vivo as an important problem. Extinction of long-term vector expression has been observed after implantation of transduced hematopoietic cells as well as fibroblasts, myoblasts and hepatocytes. Here we review the influence of vector structure, integration site and cell type on transcriptional silencing. While down-regulation of proviral transcription is known from a number of cellular and animal models, major insight has been gained from studies in the germ line and embryonal cells of the mouse. Key elements for the transfer and expression of retroviral vectors, such as the viral transcriptional enhancer and the binding site for the tRNA primer for reverse transcription may have a major influence on transcriptional silencing. Alterations of these elements of the vector backbone as well as the use of internal promoter elements from housekeeping genes may contribute to reduce transcriptional silencing. The use of cell culture and animal models in the testing and improvement of vector design is discussed. Copyright 1996 S. Karger AG, Basel
Insights
Transcriptional silencing is a key challenge in somatic gene therapy using retroviral vectors. Vector design, integration site, and cell type influence long-term gene expression, impacting therapeutic efficacy.
Area of Science:
- Gene Therapy
- Molecular Biology
- Virology
Background:
- Retroviral vectors are efficient for in vitro gene transduction.
- Transcriptional silencing in vivo limits long-term expression of retroviral vectors in somatic gene therapy.
- Observed extinction of expression in hematopoietic cells, fibroblasts, myoblasts, and hepatocytes.
Purpose of the Study:
- To review the factors influencing transcriptional silencing of retroviral vectors in vivo.
- To discuss strategies for reducing transcriptional silencing and improving vector design.
Main Methods:
- Review of existing literature on retroviral vector systems.
- Analysis of studies in germ line and embryonal mouse cells.
- Discussion of cell culture and animal models for vector testing.
Main Results:
- Vector structure, integration site, and cell type significantly impact transcriptional silencing.
- Key elements like viral enhancers and tRNA primer binding sites influence silencing.
- Alterations to vector backbone and use of internal promoters may reduce silencing.
Conclusions:
- Understanding transcriptional silencing is crucial for successful somatic gene therapy.
- Optimizing vector design through modification of key elements can enhance long-term gene expression.
- Cell culture and animal models are essential for evaluating and improving retroviral vector efficacy.